February 21, 2025

Environmental vs. Genetic Risk in Aging and Mortality

Researchers quantify the exposome's greater impact on aging and mortality risk compared with genetic predisposition, identifying 25 key environmental risk factors.

Conexiant

February 21, 2025

FDA Ends Semaglutide Shortage, Updates Policy

FDA declares resolution of nationwide semaglutide injection shortage and outlines 60 to 90 day transition periods for compounding facilities while other GLP-1 medications remain in limited supply.

Conexiant

February 21, 2025

Cardiometabolic Shifts May Predict Dementia, Study Shows

An accelerated decline in BMI and waist circumference, along with fluctuating HDL levels, may signal early cognitive impairments up to a decade before dementia diagnosis, study finds.

Conexiant

February 21, 2025

Salt, Sour Taste Loss Raises Mortality Risk

Research shows that adults experiencing perceived taste loss face a higher risk of mortality, particularly when the ability to detect salt and sourness declines.

Conexiant

February 20, 2025

Medical Oddities: Sugar Sensors in the Heart?

Sugar sensors are found in the heart. Tea ingredient turned into hydrogel. Mind-reading is getting closer. And more.

Conexiant

February 19, 2025

Oral Disease Spending Tops Ischemic Heart Disease

Spending on oral diseases ($93 billion) falls between musculoskeletal diseases ($108.6 billion) and ischemic heart disease ($80.7 billion). 

Conexiant

February 19, 2025

Smartphone Exposure Linked to Rouleaux Formation

Ultrasound study documents rapid erythrocyte aggregation in popliteal vein following 5-minute smartphone contact, suggesting potential systemic effects of radiofrequency radiation on blood viscosity.

Conexiant

February 19, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 19, 2025

Recurrent Hyperpigmented Patches After GLP-1 Therapy: What's Your Diagnosis?

A 62-year-old female developed fixed drug eruption following semaglutide administration, highlighting the importance of recognizing unusual dermatologic reactions during treatment with glucagon-like peptide-1 receptor agonists.

Conexiant